Gemina Laboratories Ltd. (CSE: GLAB)

Gemina Laboratories Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2024	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Cash & Equivalents	0	0	0.08	1.16	0.88
Cash & Short-Term Investments	0	0	0.08	1.16	0.88
Cash Growth	-98.81%	-98.81%	-92.81%	31.12%	-
Accounts Receivable	-	-	-	0.01	0.02
Other Receivables	0.04	0.04	0.39	0.18	0
Receivables	0.04	0.04	0.39	0.19	0.02
Prepaid Expenses	0.05	0.05	0.09	0.03	0.01
Restricted Cash	-	-	-	-	1.54
Total Current Assets	0.09	0.09	0.56	1.38	2.45
Property, Plant & Equipment	0.37	0.37	0.32	0.04	0.05
Long-Term Investments	0.99	0.99	0.99	-	-
Long-Term Accounts Receivable	-	-	-	-	0.01
Other Long-Term Assets	-	-	-	-	0.02
Total Assets	1.46	1.46	1.87	1.42	2.53
Accounts Payable	1.67	1.67	0.93	0.33	0.08
Accrued Expenses	0.89	0.89	0.78	0.1	0.04
Short-Term Debt	0.2	0.2	-	-	-
Current Portion of Leases	0.08	0.08	0.04	0.04	0.06
Other Current Liabilities	-	-	-	-	2.15
Total Current Liabilities	2.84	2.84	1.75	0.47	2.33
Long-Term Leases	0.21	0.21	0.2	0.01	0.04
Total Liabilities	3.04	3.04	1.95	0.48	2.37
Common Stock	11.24	11.24	8.15	5.62	0.99
Retained Earnings	-16.76	-16.76	-11.55	-5.57	-0.83
Comprensive Income & Other	3.94	3.94	3.33	0.89	-
Shareholders' Equity	-1.59	-1.59	-0.07	0.94	0.16
Total Liabilities & Equity	1.46	1.46	1.87	1.42	2.53
Total Debt	0.49	0.49	0.24	0.05	0.1
Net Cash (Debt)	-0.48	-0.48	-0.16	1.11	0.78
Net Cash Growth	-	-	-	41.65%	-
Net Cash Per Share	-0.01	-0.01	-0.00	0.02	0.02
Filing Date Shares Outstanding	73.33	73.33	73.33	55.6	38.47
Total Common Shares Outstanding	73.33	73.33	65.85	55.6	38.47
Working Capital	-2.74	-2.74	-1.19	0.91	0.12
Book Value Per Share	-0.02	-0.02	-0.00	0.02	0.00
Tangible Book Value	-1.59	-1.59	-0.07	0.94	0.16
Tangible Book Value Per Share	-0.02	-0.02	-0.00	0.02	0.00
Machinery	0.08	0.08	0.06	0.01	-
Leasehold Improvements	0.05	0.05	0.03	0.02	-

Source: S&P Capital IQ. Standard template. Financial Sources.